Onalabs: Pioneering a Paradigm Shift in Healthcare
In the vibrant city of Barcelona, a company named Onalabs has been quietly revolutionizing the healthcare landscape for the past decade. Founded by CEO Elisabet del Valle and chemist Xavier Muñoz, Onalabs is a deep tech firm that aims to transform how we monitor health. Instead of relying on sporadic blood tests, the company proposes a groundbreaking approach: continuous health monitoring through sweat analysis.
A New Era of Health Monitoring
Onalabs is on a mission to shift the paradigm in healthcare monitoring. The traditional method of conducting periodic blood tests is being challenged by a more innovative solution that focuses on “intensive” and continuous monitoring. By analyzing metabolites—molecules produced by the human body—found in sweat, Onalabs aims to provide real-time insights into an individual’s health status. This proactive approach allows for the early detection of potential health imbalances before they manifest as clinical issues.
Funding for Future Growth
To bring this innovative technology to market, Onalabs has initiated a funding round that has garnered attention from both private and public sectors. The Spanish government, through the Ministry for Digital Transformation, is set to invest up to €4.6 million in the company. This investment is part of a larger funding round totaling €9.3 million, which also includes contributions from private investors like 1921 Ventures and nPrime, both of whom have a vested interest in healthcare technology.
Elisabet del Valle describes this moment as a “turning point” for Onalabs, marking the transition from a focus on technological development to a new phase centered on industrialization and internationalization. The support from the government underscores a commitment to fostering disruptive technologies in the healthcare sector.
Real-Time Data and Preventive Medicine
The technology developed by Onalabs has the potential to revolutionize healthcare by enabling real-time monitoring of health conditions. By analyzing sweat, the company can gather large volumes of longitudinal data that, when processed through artificial intelligence, can reveal patterns and anticipate physiological changes. This shift towards preventive medicine is a significant leap forward, allowing healthcare providers to identify issues before they escalate.
Applications in Sports and Chronic Disease Management
Onalabs is not just focused on general health monitoring; it has already launched a product aimed at athletes. The ONASPORT device provides real-time biochemical parameters such as lactate levels, fluid loss, sodium concentration, dehydration levels, and heart rate. This information allows athletes to make informed decisions to optimize their performance while minimizing risks.
Moreover, the technology has broader applications, including monitoring chronic diseases like diabetes and kidney failure. The ONAVITAL device, aimed at the clinical field, is set to enhance the management of these conditions by providing continuous health insights.
Strategic Alliances for Growth
Del Valle emphasizes that Onalabs is not looking to compete with established giants in the healthcare sector. Instead, the company aims to forge strategic alliances that will integrate its technology into existing healthcare ecosystems. A notable partnership is with FC Barcelona, which invested in Onalabs through its Barça Innovation Hub. This collaboration exemplifies how Onalabs is positioning itself within the broader landscape of health technology.
Government Support and Economic Growth
The Spanish government views its investment in Onalabs as part of a broader strategy to stimulate economic growth through innovation. The Ministry for Digital Transformation aims to position Spain as a European leader in digital health, and investments like this are crucial for accelerating local manufacturing of health-focused bioelectronics. The funding comes from the European Next Generation funds, which are set to conclude at the end of the year, emphasizing the urgency and importance of this initiative.
Conclusion
Onalabs stands at the forefront of a healthcare revolution, leveraging technology to provide continuous monitoring and preventive care. With significant backing from both private investors and the Spanish government, the company is poised to make a lasting impact on how we approach health and wellness. As it embarks on this new chapter of commercialization, the potential for Onalabs to change lives and redefine healthcare is immense.
